JCG
EPRS

JHL Capital Group’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

JHL Capital Group’s Portfolio EPRS Stock Details EPRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-55,000
Closed -$243K – 30
2015
Q3 		$243K Buy
+55,000
New +$243K 0.03% 19